Table 3.
CF Nutritiona | CF Bonesb | CF Avanti | |
---|---|---|---|
Study Years | 1998–2000 | 2000–2002 | 2007–2010 |
CF Centers, n | 13 | 3 | 9 |
Sample size, nc | 78 | 101 | 58 |
Age, yrs | 7.3 ± 0.9 | 14.8 ± 4.2 | 10.3 ± 2.9 |
Range | 6.0 – 10.0 | 8.0 – 25.0 | 5.0 – 17.9 |
Vitamin A, ug/mL | |||
Mean | 52.0 ± 13.0 | 82.0 ± 29.0 | 38.0 ± 12.0 |
Median | – | 80 [33.0 – 208.0] | 38.0 [12.9 – 89.6] |
Low status (<30 ug/dL), % | 4 | 0 | 20 |
Vitamin D, ng/mL | |||
Mean | 42.6 ± 12.2d | 20.7 ± 6.5 | 32.0 ± 8.2 |
Median | 40.0 [18.9 – 79.2]d | 20.3 [4.5 – 34.9]d | 31.2 [9.3 – 77.0] |
Low status (<30ng/mL), % | 12 | 90 | 50 |
Vitamin E, | |||
αTocopherol:Cholesterol ratio | |||
Mean | 8.8 ± 3.4d | 11.4 ± 5.5d | 8.2 ± 2.2 |
Median | 8.2 [2.9 – 20.2] | 10.7 [2.9 – 27.3]d | 7.7 [2.4 ± 15.5] |
Low status (<5.4 mg/g), % | 13 | 13 | 13 |
Vitamin K, | |||
% ucOC | |||
Mean | – | 33.7 ± 17.9d | 28.7 ± 11.5 |
Median | – | 34.6 [3.1 – 76.1] | 25.3 [3.8 – 99.3] |
Low status (>50%), % | 19 | 5 | |
PIVKA II, ng/mL | |||
Mean | – | 4.6 ± 6.5d | 1.3 ± 0.7 |
Median | – | 2.1 [0 – 41.6] | 1.2 [0.3 – 16.7] |
Low status (>2.0 ng/mL), % | 50 | 19 |